跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 47,250 条关于
“anti-muscle-specific tyrosine kinase”
全部
47,250
临床试验
26,282
药物
4,831
机构
186
资讯
15,951
去年
NMD Pharma Presents Preclinical Data on ClC-1 Ion Channel Inhibition for MuSK Myasthenia Gravis Treatment
去年
UCB Pharma Eyes Further Expansion in South Korea Following Recent Drug Approvals
2年前
Nipocalimab Shows Sustained Disease Control in Adolescents with Generalized Myasthenia Gravis
去年
FDA Approves Rystiggo (rozanolixizumab-noli) for Generalized Myasthenia Gravis
10个月前
Johnson & Johnson Launches First Head-to-Head FcRn Blocker Study in Myasthenia Gravis
10个月前
UCB Presents New Clinical Data for Two Myasthenia Gravis Therapies at Major Medical Conferences
9个月前
FDA Approves UPLIZNA as First CD19-Targeted B Cell Therapy for Generalized Myasthenia Gravis
去年
Olverembatinib Shows Promise in TKI-Resistant CML and Ph+ ALL
9个月前
Tyrosine Kinase Inhibitors and Gene Therapies Show Promise for Wet AMD Treatment
2个月前
EGFR-TKIs Pose Highest Cardiovascular Risk Among Tyrosine Kinase Inhibitors, Meta-Analysis Finds
第 1 页,共 1596 页
上一页
下一页